
Citi lowered the firm’s price target on Arrowhead (ARWR) to $105 from $108 and keeps a Buy rating on the shares. The firm updated the company’s model post the fiscal
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ARWR | Arrowhead Pharmaceuticals | 43.11 | 2.53 | 6.23% |
| Name | Price | % Change | |
|---|---|---|---|
| $43.11 | +6.23% |

Citi lowered the firm’s price target on Arrowhead (ARWR) to $105 from $108 and keeps a Buy rating on the shares. The firm updated the company’s model post the fiscal

Arrowhead Pharmaceuticals, Inc. (($ARWR)) has held its Q4 earnings call. Read on for the main highlights of the call. Arrowhead Pharmaceuticals’ earnings call had a broadly optimistic tone, driven by

Arrowhead Pharmaceuticals, Inc. (ARWR) has disclosed a new risk, in the Debt & Financing category. Arrowhead Pharmaceuticals, Inc. issues Notes that do not bear regular interest and whose principal does

Morgan Stanley analyst Michael Ulz lowered the firm’s price target on Arrowhead (ARWR) to $106 from $120 and keeps an Overweight rating on the shares. Published first on TheFly –

Stifel lowered the firm’s price target on Arrowhead (ARWR) to $96 from $104 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source for

Reports FY26 revenue $450.72M, consensus $464.14M. “Arrowhead (ARWR) has fundamentally changed over the past 12 months. Where there was once a company that relied solely on great scientific promise, there

Arrowhead Pharmaceuticals, Inc. (ARWR) is scheduled to report 4th quarter earnings on 11/12/2026, after the market closes. Regarding Q4 estimates, Wall Street analysts expect Arrowhead Pharmaceuticals, Inc. to post earnings

Arrowhead (ARWR) is down -17.7%, or -$10.30 to $47.86. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on

Arrowhead (ARWR) is down -15.4%, or -$8.96 to $49.20. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on

Arrowhead (ARWR) Pharmaceuticals presented results on two of the RNA interference, RNAi, based therapies in its cardiometabolic pipeline at the American Heart Association, AHA, Scientific Sessions 2026 in Chicago. The
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Nov 17, 2026 | ||||
| buy | Reiterated | Nov 13, 2026 | ||||
| buy | Reiterated | Nov 13, 2026 | ||||
| buy | Reiterated | Nov 13, 2026 | ||||
| buy | Reiterated | Nov 13, 2026 | ||||
| buy | Reiterated | Nov 13, 2026 | ||||
| buy | Reiterated | Nov 11, 2026 | ||||
| buy | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Oct 15, 2026 | ||||
| hold | Initiated | Sep 24, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 10, 2027TBA | $6.08B | $-1.50 | $40.75M | -0.00 | -8.39 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.